Protalix BioTherapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Protalix BioTherapeutics, Inc. (PLX) reported Basic Shares Outstanding (Weighted Average) of 79.99 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 79.99M shares, a 1.68% increase year-over-year.
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 79.85M shares, a 4.23% increase year-over-year.
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 79.51M shares, a 13.23% increase year-over-year.
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 79.28M shares, a 7.79% increase year-over-year.
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 78.55M shares, a 8.29% increase from fiscal 2024.
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 72.53M shares, a 7.43% increase from fiscal 2023.
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 67.51M shares, a 39.28% increase from fiscal 2022.
- Protalix BioTherapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 48.47M shares, a 9.81% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 79.99M shares 10-Q · filed 2026-08-12 | 79.88M shares 10-Q · filed 2026-08-12 | 79.78M shares derived: average of 3 quarters · filed 2026-08-12 | 79.66M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 79.85M shares 10-Q · filed 2026-05-13 | 79.68M shares derived: average of 2 quarters · filed 2026-05-13 | 79.55M shares derived: average of 3 quarters · filed 2026-05-13 | 79.33M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 79.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 79.40M shares derived: average of 2 quarters · filed 2026-03-18 | 79.15M shares derived: average of 3 quarters · filed 2026-08-12 | 78.55M shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 79.28M shares 10-Q · filed 2025-11-13 | 78.97M shares derived: average of 2 quarters · filed 2026-08-12 | 78.23M shares 10-Q · filed 2025-11-13 | 76.19M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 78.66M shares 10-Q · filed 2026-08-12 | 77.65M shares 10-Q · filed 2026-08-12 | 75.17M shares derived: average of 3 quarters · filed 2026-08-12 | 74.76M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 76.61M shares 10-Q · filed 2026-05-13 | 73.42M shares derived: average of 2 quarters · filed 2026-05-13 | 73.46M shares derived: average of 3 quarters · filed 2026-05-13 | 73.42M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 70.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 71.88M shares derived: average of 2 quarters · filed 2026-03-18 | 72.36M shares derived: average of 3 quarters · filed 2026-03-18 | 72.53M shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 73.55M shares 10-Q · filed 2025-11-13 | 73.43M shares derived: average of 2 quarters · filed 2025-11-13 | 73.30M shares 10-Q · filed 2025-11-13 | 73.13M shares derived: average of 4 quarters · filed 2026-03-18 |
| 2024-06-30 | 73.31M shares 10-Q · filed 2025-08-14 | 73.17M shares 10-Q · filed 2025-08-14 | 72.99M shares derived: average of 3 quarters · filed 2026-03-18 | 72.81M shares derived: average of 4 quarters · filed 2026-03-18 |
| 2024-03-31 | 73.04M shares 10-Q · filed 2025-05-09 | 72.83M shares derived: average of 2 quarters · filed 2026-03-18 | 72.64M shares derived: average of 3 quarters · filed 2026-03-18 | 71.27M shares derived: average of 4 quarters · filed 2026-03-18 |
| 2023-12-31 | 72.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 72.45M shares derived: average of 2 quarters · filed 2026-03-18 | 70.69M shares derived: average of 3 quarters · filed 2026-03-18 | 67.51M shares 10-K · filed 2026-03-18 |
| 2023-09-30 | 72.28M shares 10-Q · filed 2024-11-14 | 69.72M shares derived: average of 2 quarters · filed 2024-11-14 | 65.81M shares 10-Q · filed 2024-11-14 | 62.02M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | 67.16M shares 10-Q · filed 2024-08-14 | 62.38M shares 10-Q · filed 2024-08-14 | 58.59M shares derived: average of 3 quarters · filed 2025-03-17 | 56.32M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | 57.48M shares 10-Q · filed 2024-05-10 | 54.31M shares derived: average of 2 quarters · filed 2025-03-17 | 52.71M shares derived: average of 3 quarters · filed 2025-03-17 | 51.36M shares derived: average of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | 51.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 50.32M shares derived: average of 2 quarters · filed 2025-03-17 | 49.32M shares derived: average of 3 quarters · filed 2025-03-17 | 48.47M shares 10-K · filed 2025-03-17 |
| 2022-09-30 | 49.50M shares 10-Q · filed 2023-11-06 | 48.41M shares derived: average of 2 quarters · filed 2023-11-06 | 47.58M shares 10-Q · filed 2023-11-06 | 46.99M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | 47.33M shares 10-Q · filed 2023-08-07 | 46.59M shares 10-Q · filed 2023-08-07 | 46.15M shares derived: average of 3 quarters · filed 2024-03-14 | 46.00M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | 45.84M shares 10-Q · filed 2023-05-04 | 45.56M shares derived: average of 2 quarters · filed 2024-03-14 | 45.56M shares derived: average of 3 quarters · filed 2024-03-14 | 45.53M shares derived: average of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | 45.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 45.42M shares derived: average of 2 quarters · filed 2024-03-14 | 45.42M shares derived: average of 3 quarters · filed 2024-03-14 | 44.14M shares 10-K · filed 2024-03-14 |
| 2021-09-30 | 45.56M shares 10-Q · filed 2022-11-14 | 45.50M shares derived: average of 2 quarters · filed 2022-11-14 | 43.76M shares 10-Q · filed 2022-11-14 | 41.06M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | 45.44M shares 10-Q · filed 2022-08-15 | 42.74M shares 10-Q · filed 2022-08-15 | 39.56M shares derived: average of 3 quarters · filed 2023-02-27 | 37.89M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | 39.93M shares 10-Q · filed 2022-05-16 | 36.63M shares derived: average of 2 quarters · filed 2023-02-27 | 35.37M shares derived: average of 3 quarters · filed 2023-02-27 | |
| 2020-12-31 | 33.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 33.09M shares derived: average of 2 quarters · filed 2023-02-27 | 29.15M shares 10-K · filed 2023-02-27 | |
| 2020-09-30 | 32.86M shares 10-Q · filed 2021-11-15 | 27.76M shares 10-Q · filed 2021-11-15 | ||
| 2019-12-31 | 14.84M shares 10-K · filed 2022-03-31 | |||
| 2018-06-30 | 146.64M shares 10-Q · filed 2019-03-18 | 145.99M shares 10-Q · filed 2019-03-18 | ||
| 2017-06-30 | 127.52M shares 10-Q · filed 2019-03-18 | 126.00M shares 10-Q · filed 2019-03-18 | ||
| 2016-06-30 | 99.76M shares 10-Q · filed 2017-08-09 | 99.74M shares 10-Q · filed 2017-08-09 | ||
| 2013-06-30 | 92.30M shares 10-Q · filed 2013-08-08 | 92.24M shares 10-Q · filed 2013-08-08 | ||
| 2012-06-30 | 91.53M shares 10-Q · filed 2013-08-08 | 89.70M shares 10-Q · filed 2013-08-08 | ||
| 2011-06-30 | 85.58M shares 10-Q · filed 2012-08-03 | 83.69M shares 10-Q · filed 2012-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |